Scopacasa, Beatriz S., Vicente P. A. Teixeira, and Kleber G. Franchini. Colchicine attenuates left ventricular hypertrophy but preserves cardiac function of aortic-constricted rats. J Appl Physiol 94: 1627-1633, 2003. First published December 13, 2002 10.1152/japplphysiol.00744.2002To investigate the effects of colchicine on left ventricular (LV) function and hypertrophy (LVH) of rats subjected to constriction of transverse aorta (TAoC), we evaluated SO (sham operated, vehicle; n ϭ 25), SO-T (sham operated, colchicine 0.4 mg/kg body wt ip daily; n ϭ 38), TAoC (vehicle; n ϭ 37), and TAoC-T (TAoC, colchicine; n ϭ 34) on the 2nd, 6th, and 15th day after surgery. Colchicine attenuated LVH of TAoC-T compared with TAoC rats, as evaluated by ratio between LV mass (LVM) and right ventricular mass, LV wall thickness, and average diameter of cardiac myocytes. Systolic gradient across TAoC (ϳ45 mmHg), LV systolic pressure, LV end-diastolic pressure, and rate of LV pressure increase (ϩdP/dt) were comparable in TAoC-T and TAoC rats. However, the baseline and increases of LV systolic pressure-to-LVM and ϩdP/dt-to-LVM ratios induced by phenylephrine infusion were greater in TAoC-T and SO-T compared with SO rats. Baseline and increases of ϩdP/dt-to-LVM ratio were reduced in TAoC compared with SO rats. TAoC rats increased polymerized fraction of tubulin compared with SO, SO-T, and TAoC-T rats. Our results indicate that colchicine treatment reduced LVH to pressure overload but preserved LV function. myocardium; microtubules; cytoskeleton SEVERAL OBSERVATIONAL STUDIES in genetic models and humans demonstrated that cytoskeletal alterations occurring as primary or secondary events are associated with cardiomyopathies and that, in some circumstances, such defects contribute to heart failure (3, 9-13, 16, 22). The cardiac myocyte cytoskeleton is considered to include proteins, whose primary function is to link and anchor structural components inside the cell (17). The integrity of the cytoskeleton has been shown to be central to the transduction of mechanical stress and agonist-induced stimuli into biochemical events that propagate inside the cell (7).
microtubular network as a cause for contractile impairment in pressure-overload hypertrophy, in which the increased amount of microtubules acts as a viscous element, inhibiting sarcomere shortening. Accordingly, microtubule depolymerization after either colchicine or cold exposure has been shown to return the contractile function of hypertrophic myocardium and cardiac myocytes to normal (8, 19, 24) . On the other hand, studies (14, 21) have indicated that the integrity of microtubules is important to the activation of key molecular mechanisms related to the initial hypertrophic growth induced by stretch and pressure overload. Exposure to colchicine reduced the increased expression of fetal contractile proteins and immediate early genes, as well as the increase of total cardiac RNA content in the myocardium of rats subjected to pressure overload. However, because, in such studies, the analyses were restricted to the initial molecular phenotypic changes in response to increased load, no conclusion could be drawn about the influence of microtubular integrity on cardiac mass and geometry during the hypertrophic growth. These previous observations led us to hypothesize that inhibition of tubulin polymerization by treatment with colchicine would interfere in the hypertrophic growth and simultaneously, by reducing the amount of polymerized tubulin and microtubular network, would improve the contractile function of overloaded myocardium and preserve left ventricular (LV) function.
Thus, in this study, we examined the effects of longterm treatment with colchicine on the LV hypertrophic growth and function of rats subjected to pressure overload caused by transverse aorta constriction. LV hypertrophic growth was assessed by comparing the ratio between LV (LV M ) and right ventricular (RV) mass (RV M ) in colchicine-treated and untreated rats that underwent transverse aortic constriction. LV geometry was determined from planimetric analysis of histological sections, and cardiac function was evaluated by measuring the LV pressures and the rate of increases of LV pressure (ϩdP/dt) at baseline and during hemodynamic stress caused by phenylephrine infusion.
MATERIALS AND METHODS

Animals.
The experiments were performed on male Wistar rats (140-180 g) obtained from animal facilities of the State University of Campinas (Campinas, SP, Brazil). The rats were assigned to four groups: namely, SO (sham operated, treated with saline, 100 l ip daily; n ϭ 25), SO-T (SO treated with colchicine, 0.4 mg/kg body wt ip daily; beginning the day before the surgery; n ϭ 38), TAoC (rats that underwent constriction of transverse aorta, treated with saline, 100 l ip daily; n ϭ 37), and TAoC-T (TAoC, treated with colchicine, 0.4 mg/kg body wt ip daily; beginning the day before the surgery; n ϭ 34). All procedures followed the University's guidelines to use animals in experimental studies.
Aortic constriction procedure. After anesthesia (ketamine 100 mg/kg and diazepam 6 mg/kg ip), the rats were placed on a temperature-controlled surgical table. The thoracic cavity was opened at the second left intercostal space, and a silver clip (500 m ID) was positioned in the transverse aorta just before the origin of the left common carotid artery. The thoracic cavity was closed, and the rats were maintained in a preheated chamber until they recovered from anesthesia. Sham operation was similarly performed, except that the silver clip was implanted in the thymus mass.
Experimental design and hemodynamic monitoring. After the recovery of anesthesia, the rats were moved to individual cages, where they were maintained for periods of 2, 6, or 15 days after surgery. During these periods, the rats were treated daily with single shots of saline or colchicine. At the end of each period, the rats were anesthetized, and a short (3-cm-long) heat-stretched PE-50 (external diameter ϳ200 m) cannula was inserted into the right common carotid artery and advanced into the LV for pressure measurements. A Tygon polyvinyl-tipped cannula was positioned in the lower abdominal aorta throughout the right femoral artery for the measurement of arterial pressure downstream to aortic constriction. After hemodynamic stability, baseline ventricular and aortic pressures were continuously monitored for 20 min. At the end of this period, all rats underwent a phenylephrine dose-response protocol (10-76 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ), with each dose infused for 3 min. The pressure signals were sampled at 300 Hz each, digitized, and processed with WINDAQ-PRO data-acquisition software (DATAQ Instruments, Akron, OH).
Morphological studies. After the baseline hemodynamic monitoring, the rats were euthanized with an intravenous injection of 500 l of 2% lidocaine, which induced a diastolic cardiac arrest. The hearts were excised for mass determination. The LV was then transversely sectioned in three pieces, which were immersed in phosphate-buffered formalin fixative (pH 7.2). These specimens were thin sectioned (5 m) for planimetric measurements of LV and morphometric study of cardiac myocytes by light microscopy. The LV wall thickness (LVWT) and cavity diameter (LVD) of formalin-fixed sections were analyzed by planimetric measurement. Transverse sections taken from midventricle were stained with hematoxylin and eosin. The sections were digitized directly from the slides with a commercial scanner and analyzed with NIH Image analyzer software (http://rsb.info.nih.gov/nih-image/). The same sections were used for the analysis of average diameter and the number of nuclei of cardiac myocytes per myocardial section. The diameter of isolated cardiac myocytes was measured in fibers sectioned longitudinally at the level of their nuclei.
Western blotting of free and polymerized tubulin. The Western blot analysis of tubulin was performed as described previously (8) . Briefly, a sample of LV myocardial tissue (250 mg) was homogenized in microtubule stabilizing buffer (50% glycerol, 5% DMSO, 10 mmol/l NaH2PO4, 0.5 mmol/l EGTA, 0.5 mmol/l MgSO4) and centrifuged at 100,000 g at 25°C for 10 min. The supernatants were saved as the free tubulin fractions, and the pellets were resuspended at 0°C in microtubule depolymerizing buffer (0.25 mol/l sucrose, 10 mmol/l NaH 2PO4, 0.5 mmol/l MgSO4). After 1 h at 0°C, they were centrifuged at 100,000 g at 4°C for 15 min, and the supernatants were saved as polymerized tubulin fractions. Equal proportions of the free and polymerized samples were loaded onto an 8-16% gradient SDS-PAGE, transferred to a nitrocellulose membrane, and probed with a monoclonal antibody against ␤-tubulin (Zymed). Quantification of Western blots (NIH Image analyzer software) was obtained by the integrated optical density increase over background density in a rectangular region of interest. Within a given experiment, the mean signal value in the control group was defined as 100, and the signal density for colchicine-treated rats was calculated as a percentage of the mean value obtained from SO rats within the same blot.
Statistical analysis. The results are presented as means Ϯ SE. Differences between means were tested by one-way ANOVA for repeated measures and Bonferroni's multiplerange test. A P Ͻ 0.05 was considered significant.
RESULTS
Heart mass and hemodynamics. TAoC and SO rats showed similar body weight gain along the period that followed the surgery (Table 1) . Colchicine treatment retarded the body weight gain of both TAoC-T and SO-T rats. These rats lost weight from the beginning of colchicine treatment up to the 6th day after the surgery. After this period, both groups of rats recovered their body weight gain. Changes of LV M and RV M of SO and SO-T rats paralleled the changes of body weight that occurred along the experimental period ( Table 1) . The ratio between LV M and body weight increased in TAoC and TAoC-T compared with SO and SO-T rats, respectively. However, because this index of LV hypertrophy is influenced by differences in body weight, we analyzed the ratio of LV M to RV M (LV M /RV M ), which remained stable in SO and SO-T rats over the experimental period. In TAoC, it increased significantly along the experimental period, compared with that in SO rats (Table 1 ). In addition, by the 6th and 15th day after aortic constriction, LV M /RV M values of TAoC rats were higher than the values of TAoC-T rats. Because the LV M /RV M index was not influenced by changes in body weight, this ratio was used to estimate the hypertrophic growth induced by pressure overload. By the 15th postoperative day, LV M /RV M was increased by 30% in TAoC and 15% in TAoC-T rats, compared with SO and SO-T rats, respectively. Thus we estimated that colchicine treatment reduced the load-induced LV hypertrophic growth by ϳ50%.
Stable systolic gradients of ϳ45 mmHg between the LV and abdominal aorta were seen in both TAoC and TAoC-T rats (Table 2) . Baseline LV peak systolic pressure (LVSP) was also comparable in these rats. The baseline values of LV end-diastolic pressure (LVEDP) and increasing rate of LVSP (ϩdP/dt) were similar in all groups of rats along the experimental period (Table  2) . LV function was further analyzed in response to increased systolic stress induced by intravenous infusion of phenylephrine. Figure 1 shows the changes in LVSP, LVEDP, and ϩdP/dt induced by phenylephrine in the various groups of rats on the 15th postoperative day. There were dose-dependent increases of LVSP, LVEDP, and ϩdP/dt in all groups of rats. However, at higher phenylephrine doses, TAoC and TAoC-T rats showed greater increases in LVSP than SO and SO-T rats, respectively. No significant differences were found in the responsiveness of LVEDP and ϩdP/dt to phenylephrine infusion among the groups of rats of this study.
Because at the 15th day after aortic constriction the rats of the various groups had different LV M , we also analyzed LVSP and ϩdP/dt normalized per unit of LV M . As shown in Table 3 , TAoC rats had baseline values of LVSP/LV M and ratio of ϩdP/dt to LV M (ϩdP/ dt/LV M ) significantly lower than the values of SO rats, indicating a reduced contractile performance per unit of myocardial mass. Moreover, TAoC-T and SO-T had higher values of LVSP/LV M and ϩdP/dt/LV M compared with TAoC and SO rats, respectively. These results indicate an increased baseline contractile performance per unit of mass in these rats. The analysis of the LV pressor responses to phenylephrine infusion (Fig. 2) indicated that, at higher doses of phenylephrine, TAoC-T and SO-T showed greater increases in LVSP/ LV M compared with TAoC and SO rats, respectively. SO-T and TAoC-T rats also showed greater increases of ϩdP/dt/LV M than SO and TAoC rats, respectively, in the entire range of phenylephrine doses infused in the rats. This was paralleled by an attenuation of the ϩdP/dt/LV M increases in TAoC compared with SO rats (Fig. 2) . Overall, these data are compatible with the notion that TAoC-T and SO-T rats had an increased, while TAoC rats had a decreased, contractile performance per unit of LV M than SO rats.
LV geometry and histology. TAoC rats showed a progressive increase in LV WT (Fig. 3A) . LV WT of TAoC rats increased by 33 and 72% at the 6th and 15th day, respectively, compared with values of the 2nd postoperative day. No significant change was observed in LV WT of SO, SO-T, and TAoC-T rats along the experimental period. However, LV WT values of SO-T and TAoC-T rats were lower than LV WT values of SO rats on the 6th and 15th day after surgery. Values are means Ϯ SE; n, no. of animals. LVSP, left ventricular systolic pressure; LVEDP, left ventricular end-diastolic pressure; AAbSP, abdominal aorta systolic pressure; SG, systolic gradient; HR, heart rate; ϩdP/dt, rate of increase of LV pressure. Statistical significance: *TAoC-T vs. SO; †TAoC-T vs. SO-T; ‡TAoC-T vs. TAoC; §TAoC vs. SO, P Ͻ 0.05.
The LV D was significantly increased in TAoC and TAoC-T compared with SO and SO-T rats, respectively, on the 2nd day after surgery (Fig. 3B) . However, after this period, there was a progressive reduction in the LV D of TAoC rats. In contrast, LV D of TAoC-T rats was not different than LV D of SO-T rats. The LV WT /LV D of the various experimental group are shown in Fig. 3C . TAoC caused a progressive increase in the LV WT /LV D , characterizing a concentric hypertrophy. Otherwise, TAoC-T and SO-T rats showed no significant change in LV WT /LV D , remaining similar to SO rats along the experimental period. Representative examples of LV sections of rats killed on the 15th day after the surgery are shown in Fig. 3D .
Stereological analysis of myocardial sections indicated that TAoC rats increased the average diameter of cardiac myocytes progressively along the experimental period ( Table 4 ). The average diameter of the cardiac myocytes in the remaining groups of rats did not change along the experimental period. The number of cardiac myocyte nuclei per myocardial area was slightly but significantly reduced in TAoC rats compared with the values of rats from the other groups (Table 4) .
Effects of colchicine on tubulin. To be sure that colchicine treatment effectively affected tubulin polymerization in our hands, and also to assess the effect of pressure overload on microtubules, groups of rats were prepared for Western blot analysis with anti-␤-tubulin antibody to determine the amount of free and polymerized fractions of tubulin in the myocardial homoge- nates. Figure 4 shows a representative example and average values of Western blots corresponding to polymerized and free tubulin of myocardial homogenates from the various groups of rats of this study. Most of the tubulin detected in the myocardial homogenates of SO, SO-T, TAoC, and TAoC-T rats was in the free fraction. TAoC rats showed a consistent increase in the polymerized fraction of tubulin, compared with the other groups of rats. Otherwise, TAoC-T rats showed values of polymerized slightly lower than the levels of SO rats.
DISCUSSION
Pressure overload induces LV hypertrophy that is a compensatory response to increased wall stress. This has been considered a central principle by which cardiac function is maintained within normal ranges in chronically overloaded hearts. Accordingly, suppression of myocardial hypertrophy is expected to cause heart failure. We have shown in the present study that treatment with colchicine greatly attenuated the LV hypertrophic growth and remodeling induced by sustained pressure overload, but there was no detectable impairment of LV function at baseline or during the increased systolic stress induced by phenylephrine infusion. These results indicate that treatment with colchicine allowed the LV to adapt to pressure overload, even in the absence of LV hypertrophy.
Colchicine treatment and hypertrophic growth. The attenuation of hypertrophic growth in TaoC-T rats was demonstrated by the analysis of indexes such as LV M / RV M , LV WT /LV D , and the average diameter of cardiac myocytes. Our data showed that the values of these indexes consistently increased in TAoC, whereas TAoC-T had values comparable to those of SO rats. Curiously, treatment with colchicine produced a dramatic effect on myocyte diameter, which showed no change in TAoC-T rats along the experimental period, despite the fact that these rats showed some increase in LV M . The explanation for this is not apparent from our present results but could be related to survival of a greater number of myocytes in TAoC-T compared with TAoC rats. Our data showing a reduced number of cardiac myocyte nuclei per myocardial area in TAoC rats compared with TAoC-T and SO rats accord with this idea. It is well documented that pressure overload is associated with loss of cardiac myocytes by necrosis and apoptosis (1) . Thus one could speculate that colchicine treatment, despite its effect on myocyte hypertrophic growth, might prevent the myocyte loss induced by pressure overload.
Because colchicine is a highly specific inhibitor of tubulin polymerization, it is plausible to think that the effect of colchicine treatment on LV hypertrophic growth is somehow related to this effect. Accordingly, we have shown that, in addition to reducing the LV hypertrophic growth, treatment with colchicine abrogated the increases in the amount of polymerized tubulin in overloaded myocardium. The fact that colchicine treatment did not affect specifically the LV growth or the amount of polymerized tubulin of SO-T compared with SO rats corroborates this hypothesis. Moreover, our results agree with previous observations (21) indicating that colchicine treatment abolished the expression of the early molecular markers of LV hypertrophy as well as the increased microtubule polymerization in overloaded myocardium. However, the mechanisms that relate the colchicine-induced reduction in the excessive polymerized microtubule to the inhibition of load-induced hypertrophy are still unclear and were not explored in the present study.
Colchicine treatment and cardiac function. In this study, we also showed that colchicine treatment did not compromised the LV function, despite its effect on LV hypertrophic growth of rats subjected to sustained pressure overload. Indeed, colchicine treatment was shown to be accompanied by a better contractile performance of LV per unit of myocardial mass in TAoC-T compared with TAoC rats, either at baseline or in response to increased systolic stress induced by phenylephrine infusion. Thus the enhanced contractile performance would explain the preservation of cardiac function of TAoC-T rats, despite the lack of LV hypertrophy. This generally agrees with the results of studies performed in distinct animal models of hemodynamic overload (2, 4) , supporting the concept that the LV, in the absence of a clear compensatory hypertrophy, can successfully adapt to chronic overload by enhancing myocardial contractility.
Studies in various experimental models have demonstrated that microtubule depolymerization ameliorates contractile dysfunction in cardiac myocytes (15, 19, 20, 24) and papillary muscles (25) from overloaded myocardium, suggesting that the excess of polymerized microtubules may exert negative inotropic effects by restraining the deformation of cardiac myocytes. Accordingly, this might explain the depression in contractile performance per unit mass of TAoC compared with SO rats, as well as the better contractile performance of TAoC-T rats observed in the present study. However, it is intriguing that colchicine treatment not only preserved but also improved contractile performance per unit of LV M of TAoC-T and SO-T rats. Although the explanation for these results are not apparent from our present data, the lack of detectable reduction in the amount of polymerized microtubules in the myocardium of TAoC-T and SO-T compared with SO rats would indicate that this effect may not be dependent exclusively on the disruption of myocardial microtubule network. Alternatively, colchicine treatment might directly influence the myocardial contractile per- formance. Accordingly, previous studies have shown that colchicine enhances the contractile performance by activating the excitation-contraction coupling, regulation of second messengers, and calcium signaling (5, 6) .
In summary, we have shown that colchicine treatment markedly attenuated the development of LV hypertrophy induced by pressure overload in rats, but preserved the LV function at baseline as well as at superimposed systolic stress induced by phenylephrine infusion. Furthermore, treatment with colchicine abolished the increased amount of polymerized tubulin in overloaded myocardium. These results suggest that modulation of microtubule assembly in the overloaded myocardium may, therefore, inhibit the load-induced hypertrophic growth and contribute to the preservation of the LV function, even in the presence of sustained overload.
